OCT Retinal Disease Imaging
Feb 2016Carl Zeiss AG, Camera LensesRequest Info
OBERKOCHEN, Germany, Feb. 24, 2016 — Carl Zeiss AG has announced AngioPlex optical coherence tomography (OCT) imaging technology for the diagnosis of retinal diseases.
The technology uses amplitude and phase aspects of the OCT signal, and novel algorithms to enable highly detailed visualizations of the retinal microvasculature. It detects capillary flow rather than the presence of injected dye, and can discriminate capillaries at the superficial and deep retina while generating a color map of the retinal vessels, providing a view of diseased capillaries and net structures.
Pathologies amenable to this examination include diabetic retinopathy, vein occlusions, age-related macular degeneration and pathological myopia.